Unfavorable drug interactions in targeted breast cancer therapy

Affiliations

Free article

Bernd Groner et al. Cancer Cell. 2010.

Free article

. 2010 Nov 16;18(5):401-2.

doi: 10.1016/j.ccr.2010.10.027.

¹ Georg Speyer Haus, Institute for Biomedical Research, Paul Ehrlich Str. 42, D-60596 Frankfurt am Main, Germany.

No abstract available

Comment in

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
Liang K, Esteva FJ, Albarracin C, Stemke-Hale K, Lu Y, Bianchini G, Yang CY, Li Y, Li X, Chen CT, Mills GB, Hortobagyi GN, Mendelsohn J, Hung MC, Fan Z. Liang K, et al. Cancer Cell. 2010 Nov 16;18(5):423-35. doi: 10.1016/j.ccr.2010.10.025. Cancer Cell. 2010. PMID: 21075308 Free PMC article.